Cookie Einstellungen
Diese Webseite verwendet ausschließlich notwendige Cookies, die für die Funktion erforderlich sind. Marketing- und Statistik-Cookies kommen nicht zum Einsatz. Weitere Informationen finden Sie in unserer Datenschutzerklärung.
 Notwendig   Details einblenden
      OK      
Bitte logge Dich ein, um diese Funktion zu nutzen!
      OK      
x
Impact News +++ Worthington Enterprises Q3 2026 Earnings Preview (SeekingAlpha) +++ WORTHINGTON ENTERPRISES Aktie +3,33%

GlobeNewswire EN Nachrichten

GlobeNewswire verbreitet Pressemeldungen und Pflichtmitteilungen von börsennotierten Gesellschaften. Der Großteil der Mitteilungen stammt von Unternehmen aus Nordamerika, Großbritannien und den nordeuropäischen Ländern.
 
24.03.26 - 07:03
Dupixent® (dupilumab) Approved in Japan as the First Targeted Medicine to Treat Adults with Bullous Pemphigoid (BP) (GlobeNewswire EN)
 
Approval in moderate-to-severe patients was based on pivotal trial results showing over four times more Dupixent patients experienced sustained disease remission through Week 36 compared with placebo...
24.03.26 - 07:03
Biotalys Announces New Dates for the Publication of its 2025 Annual Report and for its Annual Shareholders Meeting (GlobeNewswire EN)
 
Biotalys announces that it will publish its annual report and financial results for the full year of 2025 on Wednesday, 29 April 2026 at 07:00 CEST....
24.03.26 - 07:03
Idorsia announces the nomination of three candidates for election to the Board of Directors (GlobeNewswire EN)
 
Allschwil, Switzerland – March 24, 2026Idorsia Ltd (SIX: IDIA) announces that the Board of Directors will propose three candidates for election to the Board at the upcoming Annual General Meeting of Shareholders: Natalia Misciattelli, Chief Executive Officer and member of the Board of Directors at AAVantgarde Bio; Gabriel Baertschi, Chief Executive Officer of Grünenthal; and André C. Muller, former Chief Executive Officer of Idorsia....
24.03.26 - 07:03
Press Release: Sanofi and Regeneron′s Dupixent approved in Japan as the first targeted medicine to treat adults with bullous pemphigoid (GlobeNewswire EN)
 
Sanofi and Regeneron's Dupixent approved in Japan as the first targeted medicine to treat adults with bullous pemphigoid...
24.03.26 - 07:03
Pharming Group announces approval of Joenja® (leniolisib) in Japan for the treatment of APDS in patients aged 4 years and older (GlobeNewswire EN)
 
Leiden, the Netherlands, March 24, 2026: Pharming Group N.V. (“Pharming” or “the Company”) (EURONEXT Amsterdam: PHARM/Nasdaq: PHAR) today announced that Japan's Ministry of Health, Labour and Welfare (MHLW) has approved Joenja® (leniolisib), an oral, selective phosphoinositide 3-kinase (PI3K) delta inhibitor, for the treatment of activated PI3K delta syndrome (APDS) in adult and pediatric patients aged 4 years and older....
24.03.26 - 07:03
ABC arbitrage: 2025 Results (GlobeNewswire EN)
 
ABC Arbitrage...
24.03.26 - 04:33
Yimutian Inc. to Acquire Ningbo Xunxi Technology for RMB 50 Million, Entering the Enterprise Digital Commerce Market (GlobeNewswire EN)
 
Xunxi brings RMB 340 million in audited 2025 revenue, 200+ institutional clients, and a 2 million-member digital commerce platform....
24.03.26 - 03:48
Apollo Funds Announce Strategic Investment in NSG Group, a Global Leader in Glass Manufacturing (GlobeNewswire EN)
 
NEW YORK and TOKYO, March 23, 2026 (GLOBE NEWSWIRE) -- Apollo (NYSE:APO) today announced that Apollo-managed funds (the “Apollo Funds”) have entered into definitive agreements to execute a series of transactions to acquire Nippon Sheet Glass Company, Limited (TSE:5202) (“NSG” or the “Company”), a global leading company in architectural, automotive and solar glass. Upon completion, the transaction will be Apollo Funds' largest private equity investment in Japan to date, totaling nearly $3.7 billion (JPY ~590 billion) in enterprise value....
24.03.26 - 03:09
Progressive Prices $1.5 Billion of Senior Notes (GlobeNewswire EN)
 
MAYFIELD VILLAGE, OHIO, March 23, 2026 (GLOBE NEWSWIRE) -- The Progressive Corporation (NYSE: PGR) today announced the pricing of $500 million aggregate principal amount of its 4.60% Senior Notes due 2031 (the “2031 notes”) and $1 billion aggregate principal amount of its 5.15% Senior Notes due 2036 (the “2036 notes”, together with the “2031 notes”, the “notes”) in an underwritten public offering. The 2031 notes were priced at 99.987% of par and the 2036 notes were priced at 99.676% of par. Goldman Sachs & Co. LLC and TD Securities (USA) LLC are acting as joint bookrunners for the offering....
24.03.26 - 03:03
LOBO Announces Pricing of $2 Million Public Offering (GlobeNewswire EN)
 
WUXI, China, March 23, 2026 (GLOBE NEWSWIRE) -- LOBO TECHNOLOGIES LTD. (NASDAQ: LOBO) (“LOBO” or the “Company”), an innovative electric vehicles manufacturer and seller, today announced that it has priced a best-efforts public offering with gross proceeds to the Company expected to be approximately $2 million, before deducting placement agent fees and other estimated expenses payable by the Company, excluding the exercise of any warrant offered....
24.03.26 - 02:39
Sol-Gel Technologies Ltd. Announces Pricing of Oversubscribed Underwritten Offering (GlobeNewswire EN)
 
Sol-Gel Technologies Ltd. Announces Pricing of Oversubscribed Underwritten Offering...
24.03.26 - 02:15
Boralex Responds to Recent Statements in the Media (GlobeNewswire EN)
 
MONTRÉAL, March 23, 2026 (GLOBE NEWSWIRE) -- Boralex Inc. (the "Corporation") is aware of recent statements in the media regarding a strategic review of alternatives being conducted by the Corporation. The Corporation confirms that its Board of Directors has formed a special committee to review and recommend strategic alternatives. The special committee is continuing its strategic review and there can be no assurance that such review will result in a transaction. The Corporation remains focused on its stated business strategy and enhancing value for its shareholders. The Corporation does not intend to make any further comment unless or until there is a definitive transaction to announce or unless otherwise determined that further disclosure is appropriate or required by law....
24.03.26 - 01:06
Traction Uranium Announces Partial Conversion and Repayment of Unsecured Convertible Debentures (GlobeNewswire EN)
 
NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES...
24.03.26 - 00:09
CEMATRIX Announces $4.7 Million in New Contract Awards (GlobeNewswire EN)
 
$17.0 Million YTD in New Contract Awards $17.0 Million YTD in New Contract Awards...
24.03.26 - 00:06
Curative Biotechnology Announces Reverse Stock Split and Strategic Progress Toward OTCQB Uplisting (GlobeNewswire EN)
 
Strengthening Capital Structure and Advancing Clinical Development Strategy...
23.03.26 - 23:57
Grupo Aeroportuario del Pacifico Announces the Payment of Bond Certificate “GAP 23L” for Ps.1,120.0 Million (GlobeNewswire EN)
 
GUADALAJARA, Mexico, March 23, 2026 (GLOBE NEWSWIRE) -- Grupo Aeroportuario del Pacífico, S.A.B. de C.V. (NYSE: PAC; BMV: GAP) (“the Company” or “GAP”) announces that today it paid the maturity of the bond certificate identified as “GAP 23L,” equivalent to 11.2 million certificates for a total amount of Ps.1,120.0 million....
23.03.26 - 23:51
Fiverr Launches AI Video Hub as a New Class of Directors Challenges the Hollywood Production Model (GlobeNewswire EN)
 
Fiverr Launches AI Video Hub as a New Class of Directors Challenges the Hollywood Production Model A 30-foot hillside installation in LA signals the arriva...
23.03.26 - 23:27
Galapagos and Gilead in Advanced Discussions to Collaborate on Advancing First in Class T Cell Engager Program for Autoimmune Diseases (GlobeNewswire EN)
 
Galapagos intends to enter into a strategic collaboration with Gilead following Gilead's acquisition of Ouro Medicines...
23.03.26 - 23:15
Innovative Food Holdings, Inc. Announces Updated Fourth Quarter and Fiscal Year 2025 Earnings Call (GlobeNewswire EN)
 
BROADVIEW, Ill., March 23, 2026 (GLOBE NEWSWIRE) -- Innovative Food Holdings, Inc. (OTCQB: IVFH) (“IVFH” or the “Company”), a national seller of gourmet specialty foods, today announced an updated schedule for its conference call to discuss fourth quarter and fiscal year 2025 financial results....
>Behalte deine Investments mit realtime Kursen & News im Blick. Finde neue spannende Aktien! Registriere Dich und werde Mitglied!
Zitat des Tages: Die Frauen haben wenig Verstand, aber sehr viel Vernunft. - George Bernard Shaw
>Aktien | >Anleihen | >ETFs | >Fonds | >Branchen | >Länder | >Themen | >Redaktionen
Partner:    >TradegateBSX Börse | >Dukascopy | >TradingView | >Boersentreff- Partner

Börsentreff auf Facebook | Börsentreff auf X | Börsentreff auf Instagram

Copyright @ Boersentreff.de - Die Märkte im Blick!